Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
NCT00511082
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Hodgkin's Lymphoma(NHL)
Multiple Myeloma
Interventions
DRUG:
OPB-31121
Sponsor
Otsuka Beijing Research Institute
Collaborators
[object Object]